Search For "monoclonal"
Study gives more insight into immunotherapy treatment for ALS
Updated : 2 years, 10 months ago IST
A type of monoclonal antibody that has already been tried in certain types of cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological illness.
Read More
Researchers find dupilumab reduces disease in COPD patients with type 2 in
Updated : 2 years, 11 months ago IST
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.
Read More
Clinical use of antibodies cause life-threatening fungal infections: Study
Updated : 2 years, 11 months ago IST
Researchers found some monoclonal antibodies used in clinical trials have been linked to life-threatening systemic fungal infections. The study was published in Journal, 'Cell.'
Read More
Researchers reveal early RSV infection associated to increased risk of ast
Updated : 3 years, 1 month ago IST
The development of childhood wheezing illnesses has long been linked to severe respiratory syncytial virus (RSV) infection, but the connection between RSV infection during infancy and the emergence of childhood asthma has remained unclear.
Read More
Immunotherapy could be effective for treatment of prostate cancer: Study
Updated : 3 years, 1 month ago IST
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
Read More
Study finds how novel immunotherapy helps fight against high-risk prostat
Updated : 3 years, 1 month ago IST
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
Read More
Researchers discover new biomarker method to diagnose severe heart complic
Updated : 3 years, 5 months ago IST
Researchers at Michigan Medicine have developed a new biomarker-based technique to screen for a rare and fatal consequence caused by monoclonal antibodies, which are used to treat a variety of tumours.
Read More
Research finds how antibody therapy impacts COVID vaccines
Updated : 3 years, 5 months ago IST
Nearly three years into the pandemic, many of us now carry antibodies against the virus--due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses are created equal, and how we first developed our antibodies may influen
Read More
New treatment for atopic dermatitis shows promising result
Updated : 3 years, 5 months ago IST
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel, patient-tailored monoclonal antibody therapy--showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers report
Read More
Anifrolumab has shown long-term efficiency in lupus patients: Study
Updated : 3 years, 6 months ago IST
Type I interferon (IFN) is a strong immune activator found in high concentrations in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the first placebo-controlled long-term trial of anifrolumab, a human mon
Read More
Scientists discover new drug to lower symptoms of severe eczema
Updated : 3 years, 8 months ago IST
Illinois [US], September 24 (ANI): Researchers from Northwestern Medicine discovered a new drug that was highly effective in lowering the signs and symptoms of moderate-to-severe eczema. This is the first trial to use a biologic therapy (monoclonal antibody) instead of immune-suppressing dru
Read More
New drug helps relieve eczema's terrible itch
Updated : 3 years, 8 months ago IST
Illinois [US], September 19 (ANI): Researchers involved in a new multi-site international phase III study led by Northwestern Medicine found that a new drug was highly effective in reducing the signs and symptoms of moderate-to-severe eczema. This is the first study to treat moderate-to-seve
Read More